Author: Lorraine Mullaney
Canadian and US firms set sights on promising German cannabis market
Written by Lorraine Mullaney || 22nd June 2022 || Business briefing |
North American cannabis firms are attempting to muscle in on the German medical cannabis scene – possibly in an attempt to establish themselves in the market before a recreational regime is established ...
Canada can teach Germany about pitfalls of legalising recreational cannabis
Written by Lorraine Mullaney || 17th June 2022 || Business briefing |
Germany should plan ahead to avoid problems which have plagued governments that have already legalised recreational cannabis on top of medical cannabis ...
US at risk of missing huge opportunity in cannabis due to lack of federal reform
Written by Lorraine Mullaney || 31st May 2022 || Regulatory briefing |
The US is in danger of being left behind the burgeoning global cannabis market because of a lack of political will to commit to any form of federal cannabis reform ...
Mental health, addiction treatments with psychedelics: could the UK lead the way?
Written by Lorraine Mullaney || 27th May 2022 || Business briefing |
Strangely, Brexit and then the Covid-19 pandemic have combined to create ideal conditions for the UK to potentially become a leader in psychedelics research ...
CBD watchdog Leafreport tests sleeping products, with eye-opening results
Written by Lorraine Mullaney || 20th May 2022 || Business briefing |
The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research; however, a recent report from a CBD watchdog claims that 60% of the CBD products marketed...
Survey says Canadian cannabis companies lack consumer awareness
Written by Lorraine Mullaney || 19th May 2022 || Business briefing |
Canadian cannabis companies are about as well-liked as some of the country’s biggest oil refiners and transporters – a strange position for purveyors of one of the most mellow products on the market ...
THC lookalike products lead packaged goods group to campaign for tougher law
Written by Lorraine Mullaney || 19th May 2022 || Regulatory briefing |
A small change in proposed legislation could make it significantly easier to prevent the sale of “lookalike” cannabis products that work off existing well-known trademarks ...
New studies explore how cannabis can help improve women’s menstrual health
Written by Lorraine Mullaney || 12th May 2022 || Business briefing |
Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis ...
Canadian cannabis firms Hexo and Tilray announce new ‘strategic alliance’
Written by Lorraine Mullaney || 10th May 2022 || Business briefing |
Two major Canadian cannabis producers, Hexo and Tilray Brands, have agreed to form a “strategic alliance”, which involves Tilray acquiring Hexo’s debt in exchange for the right to purchase Hexo shares ...
Aurora expands recreational cannabis portfolio with Thrive acquisition
Written by Lorraine Mullaney || 9th May 2022 || Business briefing |
Canadian firm Aurora Cannabis is expanding its recreational portfolio with the acquisition of Ontario-based premium cannabis producer Thrive for CAD38m ($29) in cash and Aurora shares ...
Psychedelics and mental health research: hope for public and policy support
Written by Lorraine Mullaney || 27th April 2022 || Business briefing |
Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many ...
Different strokes for different folks – why the EU’s not all one for wellness CBD
Written by Lorraine Mullaney || 26th April 2022 || Regulatory briefing |
Companies selling CBD wellness products in the EU must be wary of the lack of harmonisation at the EU level and the potential complications this can bring ...
Cannabis vape innovator opens online outlet to reach CBD wellness market
Written by Lorraine Mullaney || 21st April 2022 || Business briefing |
Kanabo, the company behind the UK’s first medicinal cannabis vape, has launched an e-commerce platform to sell its VapePod products to wellness CBD consumers ...
Green energy firm plans cannabis plant on Isle of Man, avoiding UK restrictions
Written by Lorraine Mullaney || 14th April 2022 || Business briefing |
UK clean energy specialist Peel NRE has announced ambitious plans to set up a production facility for medicinal cannabis on the Isle of Man with the aim of exporting products to emerging markets beyond Europe ...
Tobacco giant BAT increases its stake in cannabis with more cash for Organigram
Written by Lorraine Mullaney || 13th April 2022 || Business briefing |
British American Tobacco (BAT) has invested a further CAD6.3m (USD5.03m) in the Canadian cannabis company Organigram, thereby increasing its stake from 18.8% to 19.5% ...
Will Canadian government’s proposal put renewed fizz in cannabinoid drinks?
Written by Lorraine Mullaney || 6th April 2022 || Blog , Business briefing |
Is the Canadian government’s proposal to increase the number of cannabis-infused drinks that can be legally purchased at one time good news for firms that have invested in cannabinoid-infused beverages? ...
New cannabis-infused drink combines an energy boost with getting high
Written by Lorraine Mullaney || 1st April 2022 || Business briefing |
A new cannabis-infused energy drink targets consumers who want to combine their workouts with getting high ...
Israeli companies predict a bright future in plants following regulatory changes
Written by Lorraine Mullaney || 28th March 2022 || Business briefing |
Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids ...
Is investing in cannabis in 2022 a smart bet or a ‘dead-money scenario’?
Written by Lorraine Mullaney || 9th March 2022 || Blog , Business briefing |
Last month CBD-Intel reported that the Dermapharm Holding bought Canopy Growth’s Cannabinoid Compound Company (C3) for €80m, a huge loss for Canopy, and one of the biggest cannabis acquisitions in Europe at the time. But what makes an acquisition a...
More medical applications for cannabinoids being explored
Written by Lorraine Mullaney || 4th March 2022 || Business briefing |
Scientists around the world are starting to look even further afield for potential uses of cannabis in medical applications, such as treating the symptoms of long Covid-19, Alzheimer’s-related agitation, and to alleviate the pain resulting from HIV ...
It’s not NORML: cannabis advocates warn against ‘illegal and unproven’ intoxicants
Written by Lorraine Mullaney || 23rd February 2022 || Business briefing |
One of the oldest surviving and best known advocacy organisations for cannabis legalisation has come out strongly against hemp-derived intoxicating cannabinoids such as delta-8 THC ...
Export expert outlines post-Brexit tips for moving goods into the UK or Europe
Written by Lorraine Mullaney || 2nd February 2022 || Regulatory briefing |
Andy Hooper, CEO of Global E-Commerce Experts, provides tips for companies wishing to export into Europe. He'll expand on this in a talk at White Label World Expo in London on 2nd and 3rd March ...
Despite industry investment, the future remains cloudy for cannabinoid drinks
Written by Lorraine Mullaney || 20th January 2022 || Blog , Business briefing |
Covid has significantly increased consumer interest in health and wellness, with food and drink formulations that create innovative solutions for “mental and emotional wellbeing” becoming a 2021 trend ...
CBD’s popularity sparks gold rush to develop rare cannabinoids
Written by Lorraine Mullaney || 19th January 2022 || Business briefing |
Potential demand for rarer cannabinoids is prompting firms to explore other methods of manufacturing, such as biosynthesis and chemical synthesis, to give higher yields at lower...
How US Democrats’ cannabis reform plans ran aground despite promises
Written by Lorraine Mullaney || 12th January 2022 || Blog , Regulatory briefing |
After early promise, no cannabis-focused legislation has yet made it onto president Joe Biden’s desk for signing. So why is that? ...
Hemp and CBD expansion in Thailand continues with government help
Written by Lorraine Mullaney || 5th January 2022 || Business briefing |
Government support of Thailand's hemp and CBD industry is paying off. Examples include US based Australis' partnership with local GTH and MPX International's agreement with Salus Thailand ...
‘Snake oil’ claims for CBD and Covid-19 top latest list of US FDA warning letters
Written by Lorraine Mullaney || 29th December 2021 || Regulatory briefing |
The most common subject of recent warning letters from the US Food and Drug Administration (FDA) over unsubstantiated health claims was CBD products that were claimed to mitigate, prevent, treat, diagnose or cure Covid-19 ...
Cannabis companies go on acquisition spree for US stores and tech companies
Written by Lorraine Mullaney || 15th December 2021 || Business briefing |
Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech companies ...
UK health trust teams up with Awakn to investigate psychedelic treatment
Written by Lorraine Mullaney || 13th December 2021 || Business briefing |
The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment ...
Growing investor interest sparks more funding for psychedelic clinical trials
Written by Lorraine Mullaney || 10th December 2021 || Business briefing |
The potential of psychedelics to treat a range of mental health conditions continues to attract increasing levels of funding for clinical trials as firms work towards bringing them into mainstream medical use ...
Multi-million, multi-state M&A deals as cannabis dispensaries spread across US
Written by Lorraine Mullaney || 17th November 2021 || Business briefing |
As the market for medical cannabis goes on growing, dispensaries continue to drive merger and acquisition activity in the US as multi-state operators invest millions of dollars in expanding their retail footprint ...
Two studies seek to show the benefits of cannabinoids for liver health
Written by Lorraine Mullaney || 5th November 2021 || Business briefing |
A research team at the University Medical Center Groningen (UMCG) in the Netherlands recently launched a three-year study into whether medicinal cannabis oil can help to regress liver-cancer tumours ...
Secondary concerns a growth area as US firms buy into cannabis industry services
Written by Lorraine Mullaney || 26th October 2021 || Business briefing |
The economic tide flowing for cannabis continues to float businesses in the US in secondary areas such as cultivation systems and delivery services too ...
Cannabis dispensaries tempt investors into multimillion US acquisitions
Written by Lorraine Mullaney || 21st October 2021 || Business briefing |
US cannabis dispensaries are attracting significant interest from investors and several multi-million dollar deals have been agreed as operators expand their footprint into new states ...
Potential for psychedelic treatments prompts big North American buyouts
Written by Lorraine Mullaney || 15th October 2021 || Business briefing |
Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres ...
Personal mental health histories lead to investments in psychedelics research
Written by Lorraine Mullaney || 12th October 2021 || Business briefing |
Two North American entrepreneurs have put millions of dollars into exploring the treatment efficacy of psychedelics, based on personal experience of using them to help deal with their own mental health issues ...
From craft beer to coffee, patience is a virtue in cannabinoid beverages
Written by Lorraine Mullaney || 4th October 2021 || Business briefing |
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens ...
Grow Group hits its crowd-funding target inside an hour – and keeps on going
Written by Lorraine Mullaney || 28th September 2021 || Business briefing |
A UK cannabis firm reached its minimum crowd-funding target of £3.2m ($4.4m) in just one hour. And the investment keeps on coming ...
US DEA calls for big increases in cannabis and psilocybin production for research
Written by Lorraine Mullaney || 23rd September 2021 || Business briefing |
The US Drug Enforcement Agency (DEA) is calling for an increase in production of cannabis and psychedelics to supply federal research and clinical trials ...
Jane Technologies raises $100m to keep rolling out cannabis e-commerce
Written by Lorraine Mullaney || 22nd September 2021 || Business briefing |
A plan to solve issues with cannabis e-commerce has attracted investors to the tune of around $130m in total ...
Cleared CBD restaurant owner: ‘I hope my case makes UK police think again’
Written by Lorraine Mullaney || 20th September 2021 || Regulatory briefing |
The long-running saga of one of the first UK police raids on a retail location selling hemp products has finally ended after a jury took just 30 minutes to reach a non-guilty verdict on drug charges ...
TerrAscend expands into Michigan with $545m purchase of Gage Growth
Written by Lorraine Mullaney || 10th September 2021 || Business briefing |
A $545m deal to buy the company Gage Growth will give North American cannabis operator TerrAscend access to the cannabis market in the US state of Michigan ...
British chef brings two-star Michelin expertise to US CBD beverage market
Written by Lorraine Mullaney || 6th September 2021 || Business briefing |
Two-star Michelin expertise is coming to the US CBD sector with the advent of a new CBD beverage with flavours developed by British chef Michael Caines ...
Investor funding drives company growth and increases cannabis research
Written by Lorraine Mullaney || 11th August 2021 || Business briefing |
New funding raised from investors will propel cannabis company expansion and research ...
US firms Ayr and Unrivaled expand their footprint across multiple states
Written by Lorraine Mullaney || 10th August 2021 || Business briefing |
US cannabis businesses continue to expand their presence into new states through mergers and acquisitions ...
Canadian cannabis firms look to the US market as they prepare to expand
Written by Lorraine Mullaney || 6th August 2021 || Business briefing |
A Canadian cannabis retailer is banking on boosts from cross-selling and increased social media presence to buoy US sales as it gobbles up accessory providers ...
Public health insurance is driving growth of the German medical cannabis market
Written by Lorraine Mullaney || 3rd August 2021 || Business briefing |
Public health insurance reimbursements and no defined list of indications for medical cannabis have helped the German medical cannabis market start to realise its massive potential ...
Watchdog study finds high levels of inaccuracy in delta-8 THC labels
Written by Lorraine Mullaney || 28th July 2021 || Business briefing |
Research from a CBD watchdog firm has found considerable inconsistencies between the levels of delta-8 THC stated on product labels and what was revealed by laboratory tests ...